Physician profile
Ali Raza
NPI 1558598862
$2,796.64
in general payments reported to CMS, 2019-2025
21 companies · $538 in 2025
The $538 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $148 · 2021: $426 · 2022: $491 · 2023: $509 · 2024: $425 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,323.30 | 2019-2025 | |
| Boston Scientific Corporation | $418.18 | 2020-2023 | Axios, Exalt Model D |
| Takeda Pharmaceuticals U.S.A., INC. | $168.68 | 2019-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $156.13 | 2019-2024 | Xifaxan |
| Orthofix Medical, INC. | $121.81 | 2023 | Truelok System, Trinity Elite, Truelok |
| Olympus America INC. | $105.03 | 2021-2024 | Single Use Aspiration Needle Na-U200h, Hanarostent Esophagus Tts(Ccc) |
| Ardelyx, INC. | $69.66 | 2022 | |
| Shire North American Group INC | $62.56 | 2019 | |
| Cook Medical LLC | $49.69 | 2022 | |
| Genzyme Corporation | $49.60 | 2024-2025 | |
| Janssen Biotech, INC. | $40.50 | 2020-2025 | Tremfya |
| Ambu INC. | $34.09 | 2024-2025 | |
| Alcresta Therapeutics, INC. | $33.20 | 2024 | Relizorb |
| Shionogi INC | $26.24 | 2019 | |
| Madrigal Pharmaceuticals | $24.65 | 2025 | Rezdiffra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $24.10 | 2019 | |
| Inari Medical, INC. | $21.32 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Aimmune Therapeutics, INC. | $20.68 | 2024 | |
| Genentech USA, INC. | $18.95 | 2021 | |
| Ucb, INC. | $15.56 | 2020 | |
| Conmed Corporation | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.